Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-25

FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application to market a generic Ranolazine product. This approval pertains to a generic version under ANDA 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

SUPPL AP for RANOLAZINE (RANOLAZINE)